Theodoros P Vassilakopoulos

Theodoros P Vassilakopoulos

National and Kapodistrian University of Athens - Athens / Greece
Medical and Health Sciences / Hematology
AD Scientific Index ID: 1847278
Εθνικού και Καποδιστριακού Πανεπιστημίου Αθηνών
person_outline Theodoros P Vassilakopoulos's MOST POPULAR ARTICLES
1-) Phase II study of the efficacy and safety of pembrolizumab for relapsed/refractory classic Hodgkin lymphomaR Chen, PL Zinzani, MA Fanale, P Armand, NA Johnson, P Brice, ...Journal of Clinical Oncology 35 (19), 2125, 20178732017
2-) Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087R Chen, PL Zinzani, HJ Lee, P Armand, NA Johnson, P Brice, J Radford, ...Blood, The Journal of the American Society of Hematology 134 (14), 1144-1153, 20192142019
3-) Selinexor in patients with relapsed or refractory diffuse large B-cell lymphoma (SADAL): a single-arm, multinational, multicentre, open-label, phase 2 trialN Kalakonda, M Maerevoet, F Cavallo, G Follows, A Goy, JSP Vermaat, ...The Lancet Haematology 7 (7), e511-e522, 20202222020
4-) Clinical approach to lymphadenopathyP GASeminars in oncology 20, 570-582, 19932271993
5-) Prognostic value of serum free light chain ratio at diagnosis in multiple myelomaMC Kyrtsonis, TP Vassilakopoulos, N Kafasi, S Sachanas, T Tzenou, ...British journal of haematology 137 (3), 240-243, 20072052007